//-->
What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
Schneeweiss, Sebastian, (1998)
On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective
Schneeweiss, Sebastian, (2001)
European Healthcare Policies for Controlling Drug Expenditure
Ess, Silvia M., (2003)